Despite price control measures, multinational medical firms fare well

Despite price control measures on medical devices, multinational firms seem to have done well. They not only secured almost 80 per cent of the total 2,000 import licenses granted in the last one year but also managed to gain market share in key segments like stents.  Sources in the Central Drug Standards Control Organisation (CDSCO) said that MNC firms have secured around 80 per cent of the device import licenses granted in the past year. These include names like Johnson and Johnson, Abbott, Medtronic, Boston Scientific and Becton Dickinson, among others. Some of these companies are.....

Key stories on are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.